ZBD: The conversion price of the convertible bonds held by the controlling shareholder will be adjusted from RMB 13.35 per share to RMB 12.35 per share

Zhitong
2025.08.20 08:14

Recently, Heilongjiang Zhenbao Island Pharmaceutical Co., Ltd. received a notice from its controlling shareholder Heilongjiang Chuangda Group Co., Ltd. that the conversion price of its first phase convertible bond "23 Chuang 01EB" in 2023 will be adjusted. This bond was issued on April 11, 2023, with a scale of 910 million yuan and a term of 3 years. To protect the interests of the bondholders, Chuangda Group decided to lower the conversion price. On August 11, the board of directors approved the adjustment, and on the 20th, the bondholders' meeting agreed to the change, with the conversion price being revised from 13.35 yuan/share to 12.35 yuan/share, effective August 27. After the adjustment, the pledged special account's preparatory stocks still meet the conversion demand

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer